CIK 0001745999 · Large accelerated filer
Beam Therapeutics Inc.
Sign in to watch- Ticker
- BEAM
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 857-327-8775
- Business address
- 26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
- Former names
- Beam Therapeutics Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,193,310
- in 2 filings, $1.2M under 10b5-1 plans
Net −$1,193,310. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-16 | Evans John M. CEO | Sale 10b5-1 | −25,000 | $23.98 | $600K | 1,047,205 |
| 2026-10-15 | Evans John M. CEO | Sale 10b5-1 | −25,000 | $23.57 | $589K | 1,047,205 |
| 2026-10-01 | Cavanagh Bethany J SVP, Finance and Treasurer | Sale 10b5-1 | −187 | $24.41 | $5K | 50,984 |
| 2026-07-27 | Simon Amy Chief Medical Officer | Sale 10b5-1 | −16,667 | $25.74 | $429K | 85,696 |
| 2026-06-30 | Simon Amy Chief Medical Officer | Sale 10b5-1 | −373 | $34.73 | $13K | 102,363 |
| 2026-06-30 | Evans John M. CEO | Sale 10b5-1 | −23,100 | $34.26 | $791K | 1,049,105 |
| 2026-06-30 | Evans John M. CEO | Sale 10b5-1 | −1,900 | $34.84 | $66K | 1,047,205 |
| 2026-06-29 | Evans John M. CEO | Sale 10b5-1 | −13,421 | $35.13 | $472K | 1,058,784 |
| 2026-06-29 | Evans John M. CEO | Sale 10b5-1 | −11,579 | $35.91 | $416K | 1,047,205 |
| 2026-06-26 | FMR LLC 10% owner | Sale | −251,488 | $35.26 | $8.9M | 854,583 |
| 2026-06-25 | FMR LLC 10% owner | Sale | −33,372 | $35.12 | $1.2M | 1,106,071 |
| 2026-04-01 | Evans John M. CEO | Sale 10b5-1 | −30,078 | $24.58 | $739K | 1,047,205 |
| 2026-04-01 | Simon Amy Chief Medical Officer | Sale 10b5-1 | −6,700 | $24.58 | $165K | 102,735 |
| 2026-04-01 | Cavanagh Bethany J SVP, Finance and Treasurer | Sale 10b5-1 | −3,242 | $24.58 | $80K | 51,171 |
| 2026-04-01 | Bellon Christine Chief Legal Officer | Sale 10b5-1 | −5,956 | $24.58 | $146K | 109,711 |
| 2026-04-01 | Ciaramella Giuseppe President | Sale 10b5-1 | −11,810 | $24.58 | $290K | 218,406 |
| 2026-03-31 | Evans John M. CEO | Sale 10b5-1 | −25,000 | $22.76 | $569K | 986,667 |
| 2026-03-30 | Evans John M. CEO | Sale 10b5-1 | −25,000 | $22.37 | $559K | 986,667 |
| 2026-02-24 | Ciaramella Giuseppe President | Sale 10b5-1 | −35,000 | $32.00 | $1.1M | 190,216 |
| 2026-01-30 | Evans John M. CEO | Sale 10b5-1 | −22,094 | $28.27 | $625K | 989,573 |
Page 1 of 13 · 249 trades